PR Newswire Clinical TrialsOriginal article
Sonorous Neurovascular Achieves First Canadian Enrollment in B-SILENT Study, Expanding Global Momentum
Trial StartB-SILENT StudyPositive
AI Analysis
Summary
Sonorous Neurovascular announced the first patient enrollment in Canada for its B-SILENT clinical study, marking an expansion of global trial enrollment for its cerebral venous disease and neurovascular intervention solutions.
Clinical Trial Data
Outcome Details
First patient enrollment in Canada achieved
Importance:4/10
Sentiment:
0.60
clinical trialmedical deviceneurovascularenrollment milestoneinternational expansioncerebral venous diseases
Read the original article
Published by PR Newswire Clinical Trials on August 3, 2026 12:34 PM